Grant: Operating Grant
University of British Columbia
$632,779.00
Microfluidic Separation of Circulating Tumor Cells
FY 2013-14
Summary
Metastasis, or the spread of cancer from one part of the body to another, is responsible for approximately 90% of all cancer related deaths. In order for cancer to spread, cells that are known as circulating tumor cells must detach from a primary tumor, circulate in the bloodstream, and reattach to a different tissue. The goal of our project is to develop technologies to capture, identify, and analyze these cells. Existing methods for capturing circulating tumor cells are known to be unreliable and do not provide the ability to extract the captured cells for further analysis. We will address these key limitations by using an innovative mechanism to isolate these cells based on their physical characteristics and then positively identify them using known molecular markers. Our approach has the potential to enable major advances in the research and treatment of many types of cancers. Specifically, the presence of circulating tumor cells can provide an early indication of disease, while the number and status of these cells can be used to select personalized drugs and dosage levels to most appropriately treat each patient. Furthermore, analysis of the molecular characteristics of circulating tumor cells can help to elucidate the underlying mechanisms of metastasis and help to identify targets for new drugs.
Department
Program
Operating Grant
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
292244
Name
Ma Hongshen
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Biomedical Engineering
Projecttitle
Microfluidic Separation of Circulating Tumor Cells
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$632,779
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Biomechanics; Circulating Tumor Cells; Deformability; Lab-On-A-Chip; Medical Device; Microfluidics; Prostate Cancer
Abstract
Metastasis, or the spread of cancer from one part of the body to another, is responsible for approximately 90% of all cancer related deaths. In order for cancer to spread, cells that are known as circulating tumor cells must detach from a primary tumor, circulate in the bloodstream, and reattach to a different tissue. The goal of our project is to develop technologies to capture, identify, and analyze these cells. Existing methods for capturing circulating tumor cells are known to be unreliable and do not provide the ability to extract the captured cells for further analysis. We will address these key limitations by using an innovative mechanism to isolate these cells based on their physical characteristics and then positively identify them using known molecular markers. Our approach has the potential to enable major advances in the research and treatment of many types of cancers. Specifically, the presence of circulating tumor cells can provide an early indication of disease, while the number and status of these cells can be used to select personalized drugs and dosage levels to most appropriately treat each patient. Furthermore, analysis of the molecular characteristics of circulating tumor cells can help to elucidate the underlying mechanisms of metastasis and help to identify targets for new drugs.
Competitiondate
201309
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Ma, Hongshen
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $632,779~ $0~